Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.16 USD | -0.62% |
|
-2.11% | -20.17% |
06-27 | Dynavax Reports First Participant Dosed in Shingles Vaccine Trial | MT |
06-27 | Dynavax Technologies Corporation Initiates Phase 1/2 Study of Novel Shingles Vaccine Program | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.17% | 1.46B | |
+15.82% | 122B | |
+20.35% | 114B | |
+17.47% | 25.71B | |
-25.31% | 19.02B | |
-19.51% | 15.83B | |
-19.67% | 15.32B | |
-46.87% | 14.88B | |
+62.55% | 14.82B | |
+6.34% | 14.1B |
- Stock Market
- Equities
- DVAX Stock
- News Dynavax Technologies Corporation
- Dynavax Technologies : Elects Scott Myers as Board Chairman